Evaluation of Inflammatory Biomarker IL-8 in Helicobacter Pylori-Associated Gastritis

Authors

Mohammed Ejresh

NA (India)

Alya A. Rahi

NA (India)

Article Information

DOI: 10.51244/IJRSI.2026.1315PH00088

Subject Category: Microbiology

Volume/Issue: 13/15 | Page No: 2400-2406

Publication Timeline

Submitted: 2026-05-21

Accepted: 2026-04-26

Published: 2026-05-15

Abstract

Helicobacter pylori gastritis has been recognized as a significant risk factor for the development of gastric cancer. This study aimed to evaluate the role of interleukin-8 (IL-8) in Helicobacter pylori-Associated Gastritis disease progression. A total of 65 participants in the present study 35(58%)with symptoms of gastritis, were diagnosed and included in the study, along with 25 healthy controls. Gastric biopsy samples (mucus layer) were collected, and IL-8 concentrations were measured using an ELISA assay (Solarbio Human IL-8 ELISA Kit). Absorbance was recorded using a Fisher Scientific ELISA plate reader. Patients with gastritis who tested positive for Helicobacter pylori by PCR analysis—using glmM-specific primers—showed significantly elevated levels of IL-8 compared to healthy controls (17.78 pg/mL vs. 9.05 pg/mL, p < 0.001). These findings demonstrate a marked increase in IL-8 levels in patients with H. pylori-induced gastritis, underscoring its critical role in mediating inflammatory responses and contributing to disease pathogenesis.

Keywords

IL-8, glmM, PCR,Helicobacter. pylori, ureC

Downloads

References

1. Malespín-Bendaña W, Alpízar-Alpízar W, Figueroa-Protti L, Reyes L, Molina-Castro S, Une C, et al. Helicobacter pylori infection induces gastric precancerous lesions and persistent expression of Angpt2, Vegf-A and Tnf-A in a mouse model. Front Oncol. 2023;13:1072802. [Google Scholar] [Crossref]

2. Yan L, Chen Y, Chen F, Tao T, Hu Z, Wang J, et al. Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology. 2022;163(1):154–62. e3. [Google Scholar] [Crossref]

3. Usui Y, Taniyama Y, Endo M, Koyanagi YN, Kasugai Y, Oze I, et al. Helicobacter pylori, homologous-recombination genes, and gastric cancer. N Engl J Med. 2023;388(13):1181–90. [Google Scholar] [Crossref]

4. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53. [Google Scholar] [Crossref]

5. Hui Y, Tu C, Liu D, Zhang H, Gong X. Risk factors for gastric cancer: a comprehensive analysis of observational studies. Front Public Health. 2023;10:892468. [Google Scholar] [Crossref]

6. Mukherjee S, Ghatak S, Chhuani L, Lalrinpuia B, Jahau L, Pautu JL, et al. Helicobacter pylori virulent genes and host interleukin 1 are associated with demographic factors for an increased risk of gastritis. Hum Gene. 2022;34:201132. [Google Scholar] [Crossref]

7. Inoue I, Yoshimura N, Iidaka T, Horii C, Muraki S, Oka H, et al. Trends in the prevalence of atrophic gastritis and Helicobacter pylori infection over a 10–year period in Japan: the ROAD study 2005–2015. Mol Clin Oncol. 2023;19(1):1–9. [Google Scholar] [Crossref]

8. Shichijo S, Uedo N, Michida T. Detection of early gastric cancer after Helicobacter pylori eradication. Digestion. 2022;103(1):54–61. [Google Scholar] [Crossref]

9. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neurooncology. 2005;7(2):122–33. [Google Scholar] [Crossref]

10. Ma Y, Fu Y, Fan X, Ji Q, Duan X, Wang Y, et al. FAK/IL-8 axis promotes the proliferation and migration of gastric cancer cells. Gastric Cancer. 2023;26(4):528–41. [Google Scholar] [Crossref]

11. Li X, Zhai J, Shen Y, Zhang T, Wang Y, He Y, et al. Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8 + T cells. Cancer Immunol Immunother. 2022;71(12):3057–70. [Google Scholar] [Crossref]

12. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735–41. [Google Scholar] [Crossref]

13. In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, et al. Serum pepsinogen as a biomarker for gastric cancer in the United States: a nested case–control study using the PLCO cancer screening trial data. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1426–32. [Google Scholar] [Crossref]

14. Kuepethkaew S, Zhang Y, Kishimura H, Kumagai Y, Simpson BK, Benjakul S, et al. Enzymological characteristics of pepsinogens and pepsins purified from lizardfish (Saurida micropectoralis) stomach. Food Chem. 2022;366:130532. [Google Scholar] [Crossref]

15. Pourakbari, B., Ghazi, M., Mahmoudi, S., Mamishi, S., Azhdarkosh, H., Najafi, M., ... & Mirsalehian, A. (2013). Diagnosis of Helicobacter pylori infection by invasive and noninvasive tests. Brazilian Journal of Microbiology, 44(3), 795-798.‏ [Google Scholar] [Crossref]

16. Öztekin, M., Yılmaz, B., Ağagündüz, D., & Capasso, R. (2021). Overview of Helicobacter pylori infection: clinical features, treatment, and nutritional aspects. Diseases, 9(4), 66.‏ [Google Scholar] [Crossref]

17. Sharma, P., Phatak, S. M., Warikoo, P., Mathur, A., Mahant, S., Das, K., & Das, R. (2023). Crosstalk between Helicobacter pylori and gastrointestinal microbiota in various gastroduodenal diseases—a systematic review. 3 Biotech, 13(9), 303.‏ [Google Scholar] [Crossref]

18. Wroblewski, L. E., & Peek Jr, R. M. (2024). Clinical pathogenesis, molecular mechanisms of gastric cancer development. In Helicobacter pylori and Gastric Cancer (pp. 25-52). Cham: Springer Nature Switzerland.‏ [Google Scholar] [Crossref]

19. Al-Mahdawi, M. A. S., Ahmed, A. K., & Ali, G. H. (2017). Detection of cagA and vacA Helicobacter pylori Virulence Genes in Gastric Biopsies of patients with Gastroduodenal disease using Polymerase chain reaction (PCR) technique. Diyala Journal for pure science, 13(4). [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles